Announcements Trials
Browse Landscape

Phase

Phase 2 43Phase 1 29Phase 3 17Phase 1/2 7Phase NA 2Phase EARLY_PHASE1 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 4Plasma cell 3Other hematologic neoplasm 2CNS 2

Conditions

Rhabdoid Tumor 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasm Metastasis 1Medulloblastoma 1Brain Neoplasms 1

Interventions

Temozolomide 17Magnetic Resonance Spectroscopy 16Radiotherapy 10Bevacizumab 7fluciclovine F-18 6Specimen Handling 6Topotecan 5Cyclophosphamide 5Biopsy 5fluorodopa F 18 4abemaciclib 4Vincristine 4Surgical Procedures, Operative 4Ketoconazole 4Irinotecan 4Fluorodeoxyglucose F18 4Ferrosoferric Oxide 4ribociclib 3gallium Ga 68 dotatate 3etoposide phosphate 3Radiation 3Pemetrexed 3Nivolumab 3Methotrexate 3Mesna 3Everolimus 3Etoposide 3Carboplatin 3posaconazole 2poly ICLC 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Filgrastim × CNS × Clear all
NCT06942039 2026-02-27

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

C17 Council

Phase EARLY_PHASE1 Recruiting
15 enrolled
CNS

Medulloblastoma, Neuroblastoma, Pinealoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor, Pyloric Stenosis, Hypertrophic

NCT02774291 2023-08-04

Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes

Albert Einstein College of Medicine

Phase EARLY_PHASE1 Terminated
3 enrolled 6 charts
CNS

Brain Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡